The DOI matches its Crossref record; 183 of the 183 references it cites were found in a registry or an index.
Lipid-based systemic delivery of siRNA
Open accessAbstract
RNAi technology has brought a new category of treatments for various diseases including genetic diseases, viral diseases, and cancer. Despite the great versatility of RNAi that can down regulate almost any protein in the cells, the delicate and precise machinery used for silencing is the same. The major challenge indeed for RNAi-based therapy is the delivery system. In this review, we start with the uniqueness and mechanism of RNAi machinery and the utility of RNAi in therapeutics. Then we discuss the challenges in systemic siRNA delivery by dividing them into two categories--kinetic and physical barriers. At the end, we discuss different strategies to overcome these barriers, especially focusing on the step of endosome escape. Toxicity issues and current successful examples for lipid-based delivery are also included in the review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
The nuclear RNase III Drosha initiates microRNA processing
Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., Lee, J., Provost, P., Rådmark, O., Kim, S., et al. (2003) · Nature · doi:10.1038/nature01957 · Cited by 5,114
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,291
Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S., & Fujita, T. (2004) · Nature Immunology · doi:10.1038/ni1087 · Cited by 3,929
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, K. J., et al. (2006) · Nature · doi:10.1038/nature04734 · Cited by 3,888
Asymmetry in the Assembly of the RNAi Enzyme Complex
Schwarz, D. S., Hutvágner, G., Du, T., Xu, Z., Aronin, N., & Zamore, P. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00759-1 · Cited by 2,922
Samson, M., Libert, F., Doranz, B. J., Rucker, J., Liesnard, C., Farber, C.-M., Saragosti, S., Lapouméroulie, C., Cognaux, J., Forceille, C., et al. (1996) · Nature · doi:10.1038/382722a0 · Cited by 2,886
Biogenesis of small RNAs in animals
Kim, V. N., Han, J., & Siomi, M. C. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2632 · Cited by 2,814
Argonaute2 is the catalytic engine of mammalian RNAi
Liu, J., Carmell, M. A., Rivas, F. V., Marsden, C. G., Thomson, J. M., Song, J.-J., Hammond, S. M., Joshua-Tor, L., & Hannon, G. J. (2004) · Science · doi:10.1126/science.1102513 · Cited by 2,796
Functional siRNAs and miRNAs exhibit strand bias
Khvorova, A., Reynolds, A., & Jayasena, S. D. (2003) · Cell · doi:10.1016/s0092-8674(03)00801-8 · Cited by 2,645
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs
Meister, G., Landthaler, M., Patkaniowska, A., Dorsett, Y., Teng, G., & Tuschl, T. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.07.007 · Cited by 2,052
Exploiting the enhanced permeability and retention effect for tumor targeting
Iyer, A. K., Khaled, G., Fang, J., & Maeda, H. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.07.005 · Cited by 1,846
Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA
Liu, F., Song, Y. K., & Liu, D. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300947 · Cited by 1,727
Openings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells
Paddison, P. J., Caudy, A. A., Bernstein, E., Hannon, G. J., & Conklin, D. S. (2002) · Genes & Development · doi:10.1101/gad.981002 · Cited by 1,552
Single-Stranded Antisense siRNAs Guide Target RNA Cleavage in RNAi
Martinez, J., Patkaniowska, A., Urlaub, H., Lührmann, R., & Tuschl, T. (2002) · Cell · doi:10.1016/s0092-8674(02)00908-x · Cited by 1,459
Saito, G., Swanson, J. A., & Lee, K.-D. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00179-5 · Cited by 1,407
Activation of the interferon system by short-interfering RNAs
Sledz, C. A., Holko, M., de Veer, M. J., Silverman, R. H., & Williams, B. R. G. (2003) · Nature Cell Biology · doi:10.1038/ncb1038 · Cited by 1,400
RNAi-mediated gene silencing in non-human primates
Zimmermann, T. S., Lee, A. C. H., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., et al. (2006) · Nature · doi:10.1038/nature04688 · Cited by 1,357
Regulation by let-7 and lin-4 miRNAs Results in Target mRNA Degradation
Bagga, S., Bracht, J., Hunter, S., Massirer, K., Holtz, J., Eachus, R., & Pasquinelli, A. E. (2005) · Cell · doi:10.1016/j.cell.2005.07.031 · Cited by 1,346
Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis
Akinc, A., Thomas, M., Klibanov, A. M., & Langer, R. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.696 · Cited by 1,337
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., & MacLachlan, I. (2005) · Nature Biotechnology · doi:10.1038/nbt1081 · Cited by 1,250
Hornung, V., Guenthner-Biller, M., Bourquin, C., Ablasser, A., Schlee, M., Uematsu, S., Noronha, A., Manoharan, M., Akira, S., de Fougerolles, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1191 · Cited by 1,232
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
Morrissey, D. V., Lockridge, J. A., Shaw, L., Blanchard, K., Jensen, K., Breen, W., Hartsough, K., Machemer, L., Radka, S., Jadhav, V., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1122 · Cited by 1,168
Mechanism of DNA Release from Cationic Liposome/DNA Complexes Used in Cell Transfection,
Xu, Y., & Szoka, F. C. (1996) · Biochemistry · doi:10.1021/bi9602019 · Cited by 1,134
RNA interference targeting Fas protects mice from fulminant hepatitis
Song, E., Lee, S.-K., Wang, J., Ince, N., Ouyang, N., Min, J., Chen, J., Shankar, P., & Lieberman, J. (2003) · Nature Medicine · doi:10.1038/nm828 · Cited by 1,110
A DNA vector-based RNAi technology to suppress gene expression in mammalian cells
Sui, G., Soohoo, C., Affar, E. B., Gay, F., Shi, Y., Forrester, W. C., & Shi, Y. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082117599 · Cited by 1,104
Napoli, C., Lemieux, C., & Jorgensen, R. (1990) · The Plant Cell · doi:10.2307/3869076 · Cited by 1,101
Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes
Sonawane, N. D., Szoka, F. C., & Verkman, A. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308643200 · Cited by 1,081
RNA interference in adult mice
McCaffrey, A. P., Meuse, L., Pham, T.-T. T., Conklin, D. S., Hannon, G. J., & Kay, M. A. (2002) · Nature · doi:10.1038/418038a · Cited by 1,059
Single Processing Center Models for Human Dicer and Bacterial RNase III
Zhang, H., Kolb, F. A., Jaskiewicz, L., Westhof, E., & Filipowicz, W. (2004) · Cell · doi:10.1016/j.cell.2004.06.017 · Cited by 1,041
Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras
McNamara, J. O., Andrechek, E. R., Wang, Y., Viles, K. D., Rempel, R. E., Gilboa, E., Sullenger, B. A., & Giangrande, P. H. (2006) · Nature Biotechnology · doi:10.1038/nbt1223 · Cited by 1,002
Induction of an interferon response by RNAi vectors in mammalian cells
Bridge, A. J., Pebernard, S., Ducraux, A., Nicoulaz, A.-L., & Iggo, R. (2003) · Nature Genetics · doi:10.1038/ng1173 · Cited by 961
Total silencing by intron-spliced hairpin RNAs
Smith, N. A., Singh, S. P., Wang, M.-B., Stoutjesdijk, P. A., Green, A. G., & Waterhouse, P. M. (2000) · Nature · doi:10.1038/35030305 · Cited by 957
Widespread siRNA “off-target” transcript silencing mediated by seed region sequence complementarity
Jackson, A. L., Burchard, J., Schelter, J., Chau, B. N., Cleary, M., Lim, L., & Linsley, P. S. (2006) · RNA · doi:10.1261/rna.25706 · Cited by 956
Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells
Lee, N. S., Dohjima, T., Bauer, G., Li, H., Li, M.-J., Ehsani, A., Salvaterra, P., & Rossi, J. (2002) · Nature Biotechnology · doi:10.1038/nbt0502-500 · Cited by 953
Zhang, G., Budker, V., & Wolff, J. A. (1999) · Human Gene Therapy · doi:10.1089/10430349950017734 · Cited by 944
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
Kleinman, M. E., Yamada, K., Takeda, A., Chandrasekaran, V., Nozaki, M., Baffi, J. Z., Albuquerque, R. J. C., Yamasaki, S., Itaya, M., Pan, Y., et al. (2008) · Nature · doi:10.1038/nature06765 · Cited by 929
RNAi therapeutics: Principles, prospects and challenges
Aagaard, L., & Rossi, J. J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.005 · Cited by 895
Stable suppression of tumorigenicity by virus-mediated RNA interference
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00122-8 · Cited by 886
siRNA function in RNAi: A chemical modification analysis
CHIU, Y.-L., & RANA, T. M. (2003) · RNA · doi:10.1261/rna.5103703 · Cited by 860
Effective expression of small interfering RNA in human cells
Paul, C. P., Good, P. D., Winer, I., & Engelke, D. R. (2002) · Nature Biotechnology · doi:10.1038/nbt0502-505 · Cited by 820
Prospects for cationic polymers in gene and oligonucleotide therapy against cancer
Merdan, T., Kopec̆ek, J., & Kissel, T. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00046-7 · Cited by 785
siRNA-directed inhibition of HIV-1 infection
Novina, C. D., Murray, M. F., Dykxhoorn, D. M., Beresford, P. J., Riess, J., Lee, S.-K., Collman, R. G., Lieberman, J., Shankar, P., & Sharp, P. A. (2002) · Nature Medicine · doi:10.1038/nm725 · Cited by 773
Needham, D., Anyarambhatla, G., Kong, G., & Dewhirst, M. W. (2000) · PubMed · Cited by 746
Modulation of HIV-1 replication by RNA interference
Jacque, J.-M., Triques, K., & Stevenson, M. (2002) · Nature · doi:10.1038/nature00896 · Cited by 719
Urban-Klein, B., Werth, S., Abuharbeid, S., Czubayko, F., & Aigner, A. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302425 · Cited by 716
Qin, X.-F., An, D. S., Chen, I. S. Y., & Baltimore, D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232688199 · Cited by 701
Dalby, B. (2004) · Methods · doi:10.1016/j.ymeth.2003.11.023 · Cited by 619
Inhibition of hepatitis B virus in mice by RNA interference
McCaffrey, A. P., Nakai, H., Pandey, K., Huang, Z., Salazar, F. H., Xu, H., Wieland, S. F., Marion, P. L., & Kay, M. A. (2003) · Nature Biotechnology · doi:10.1038/nbt824 · Cited by 607
On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids
Hafez, I., Maurer, N., & Cullis, P. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301506 · Cited by 601
Lee, J., Chuang, T.-H., Redecke, V., She, L., Pitha, P. M., Carson, D. A., Raz, E., & Cottam, H. B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0631696100 · Cited by 592
In vivo activity of nuclease-resistant siRNAs
LAYZER, J. M., MCCAFFREY, A. P., TANNER, A. K., HUANG, Z., KAY, M. A., & SULLENGER, B. A. (2004) · RNA · doi:10.1261/rna.5239604 · Cited by 580
Design of Noninflammatory Synthetic siRNA Mediating Potent Gene Silencing in Vivo
Judge, A. D., Bola, G., Lee, A. C. H., & MacLachlan, I. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.002 · Cited by 571
T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice
Kumar, P., Ban, H.-S., Kim, S.-S., Wu, H., Pearson, T., Greiner, D. L., Laouar, A., Yao, J., Haridas, V., Habiro, K., et al. (2008) · Cell · doi:10.1016/j.cell.2008.06.034 · Cited by 570
Zhang, G., Yang, Z., Lu, W., Zhang, R., Huang, Q., Tian, M., Li, L., Liang, D., & Li, C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.038 · Cited by 563
Thomas, M., & Klibanov, A. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1233634100 · Cited by 549
Heil, F., Ahmad‐Nejad, P., Hemmi, H., Hochrein, H., Ampenberger, F., Gellert, T., Dietrich, H., Lipford, G., Takeda, K., Akira, S., et al. (2003) · European Journal of Immunology · doi:10.1002/eji.200324238 · Cited by 518
Heritable gene silencing in Drosophila using double-stranded RNA
Kennerdell, J. R., & Carthew, R. W. (2000) · Nature Biotechnology · doi:10.1038/78531 · Cited by 508
Off-target effects by siRNA can induce toxic phenotype
Fedorov, Y., Anderson, E. M., Birmingham, A., Reynolds, A., Karpilow, J., Robinson, K., Leake, D., Marshall, W. S., & Khvorova, A. (2006) · RNA · doi:10.1261/rna.28106 · Cited by 490
Enhancing polyethylenimine's delivery of plasmid DNA into mammalian cells
Thomas, M., & Klibanov, A. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192581499 · Cited by 483
In vivo gene transfer via intravenous administration of cationic lipid–protamine–DNA (LPD) complexes
Li, S., & Huang, L. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300482 · Cited by 475
Self-citationLiposome-based drug delivery in breast cancer treatment
Park, J. W. (2002) · Breast Cancer Research · doi:10.1186/bcr432 · Cited by 469
Chemical Approaches to Triggerable Lipid Vesicles for Drug and Gene Delivery
Guo, X., & Szoka, F. C. (2003) · Accounts of Chemical Research · doi:10.1021/ar9703241 · Cited by 456
siRNA and miRNA: an insight into RISCs
Tang, G. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.12.007 · Cited by 449
Purification of polyethylenimine polyplexes highlights the role of free polycations in gene transfer
Boeckle, S., von Gersdorff, K., van der Piepen, S., Culmsee, C., Wagner, E., & Ogris, M. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.598 · Cited by 447
Heritable and inducible genetic interference by double-stranded RNA encoded by transgenes
Tavernarakis, N., Wang, S. L., Dorovkov, M., Ryazanov, A., & Driscoll, M. (2000) · Nature Genetics · doi:10.1038/72850 · Cited by 424
Coburn, G. A., & Cullen, B. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.18.9225-9231.2002 · Cited by 413
Human Immunodeficiency Virus Type 1 Escape from RNA Interference
Boden, D., Pusch, O., Lee, F., Tucker, L., & Ramratnam, B. (2003) · Journal of Virology · doi:10.1128/jvi.77.21.11531-11535.2003 · Cited by 412
Allele-specific silencing of dominant disease genes
Miller, V. M., Xia, H., Marrs, G. L., Gouvion, C. M., Lee, G., Davidson, B. L., & Paulson, H. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1231012100 · Cited by 400
Hatakeyama, H., Akita, H., Kogure, K., Oishi, M., Nagasaki, Y., Kihira, Y., Ueno, M., Kobayashi, H., Kikuchi, H., & Harashima, H. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302843 · Cited by 398
Interference of hepatitis C virus RNA replication by short interfering RNAs
Kapadia, S. B., Brideau-Andersen, A., & Chisari, F. V. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252783999 · Cited by 392
5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma
Poeck, H., Besch, R., Maihoefer, C., Renn, M., Tormo, D., Morskaya, S. S., Kirschnek, S., Gaffal, E., Landsberg, J., Hellmuth, J., et al. (2008) · Nature Medicine · doi:10.1038/nm.1887 · Cited by 387
Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase
Kim, D.-H., Longo, M., Han, Y., Lundberg, P., Cantin, E., & Rossi, J. J. (2004) · Nature Biotechnology · doi:10.1038/nbt940 · Cited by 382
A Small Interfering RNA Targeting Vascular Endothelial Growth Factor as Cancer Therapeutics
Takei, Y., Kadomatsu, K., Yuzawa, Y., Matsuo, S., & Muramatsu, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2682 · Cited by 378
Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded
Cattaneo, R., Miest, T., Shashkova, E. V., & Barry, M. A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1927 · Cited by 373
A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium
Santel, A., Aleku, M., Keil, O., Endruschat, J., Esche, V, Fisch, G., Dames, S., Löffler, K., Fechtner, M., Arnold, W., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302777 · Cited by 368
Thomas, M., Lu, J. J., Ge, Q., Zhang, C., Chen, J., & Klibanov, A. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502067102 · Cited by 366
Konno, T., Maeda, H., Iwai, K., Tashiro, S., Maki, S., Morinaga, T., Mochinaga, M., Hiraoka, T., & Yokoyama, I. (1983) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(83)90028-7 · Cited by 342
Anion-Mediated Transfer of Polyarginine across Liquid and Bilayer Membranes
Sakai, N., & Matile, S. (2003) · Journal of the American Chemical Society · doi:10.1021/ja037601l · Cited by 341
The dsRNA binding protein family: critical roles, diverse cellular functions
SAUNDERS, L. R., & BARBER, G. N. (2003) · The FASEB Journal · doi:10.1096/fj.02-0958rev · Cited by 338
Tumor-targeted Delivery of siRNA by Self-assembled Nanoparticles
Li, S.-D., Chen, Y.-C., Hackett, M. J., & Huang, L. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300323 · Cited by 333
Self-citationBiophysical and Structural Characterization of Polyethylenimine-Mediated siRNA Delivery in Vitro
Richards Grayson, A. C., Doody, A. M., & Putnam, D. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9009-2 · Cited by 324
Martin, M. E., & Rice, K. G. (2007) · The AAPS Journal · doi:10.1208/aapsj0901003 · Cited by 319
Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imaging
Yang, J., Chen, H., Vlahov, I. R., Cheng, J.-X., & Low, P. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601455103 · Cited by 318
Surfactant-induced sealing of electropermeabilized skeletal muscle membranes in vivo.
Lee, R. C., River, L. P., Pan, F. S., Ji, L., & Wollmann, R. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4524 · Cited by 306
Wilson, J. A., Jayasena, S., Khvorova, A., Sabatinos, S., Rodrigue-Gervais, I. G., Arya, S., Sarangi, F., Harris-Brandts, M., Beaulieu, S., & Richardson, C. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252758799 · Cited by 302
Inhibition of HIV-1 Infection by Small Interfering RNA-Mediated RNA Interference
Capodici, J., Karikó, K., & Weissman, D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.5196 · Cited by 302
Halder, J., Kamat, A. A., Landen, C. N., Han, L. Y., Lutgendorf, S. K., Lin, Y. G., Merritt, W. M., Jennings, N. B., Chavez-Reyes, A., Coleman, R. L., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0021 · Cited by 297
Pharmacokinetic Properties of 2′-O-(2-Methoxyethyl)-Modified Oligonucleotide Analogs in Rats
Geary, R. S., Watanabe, T. A., Truong, L., Freier, S., Lesnik, E. A., Sioufi, N. B., Sasmor, H., Manoharan, M., & Levin, A. A. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38831-7 · Cited by 288
Live‐cell analysis of cell penetration ability and toxicity of oligo‐arginines
Tünnemann, G., Ter‐Avetisyan, G., Martin, R. M., Stöckl, M., Herrmann, A., & Cardoso, M. C. (2008) · Journal of Peptide Science · doi:10.1002/psc.968 · Cited by 286
Overcoming the Innate Immune Response to Small Interfering RNA
Judge, A., & MacLachlan, I. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.179 · Cited by 284
Physicochemical and Biological Characterization of Targeted, Nucleic Acid-Containing Nanoparticles
Bartlett, D. W., & Davis, M. E. (2007) · Bioconjugate Chemistry · doi:10.1021/bc0603539 · Cited by 283
Li, S.-D., & Huang, L. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060039w · Cited by 282
Self-citationWerth, S., Urban-Klein, B., Dai, L., Höbel, S., Grzelinski, M., Bakowsky, U., Czubayko, F., & Aigner, A. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.02.009 · Cited by 281
Banerjee, R., Tyagi, P., Li, S., & Huang, L. (2004) · International Journal of Cancer · doi:10.1002/ijc.20452 · Cited by 274
Self-citationDesigning siRNA That Distinguish between Genes That Differ by a Single Nucleotide
Schwarz, D. S., Ding, H., Kennington, L., Moore, J. T., Schelter, J., Burchard, J., Linsley, P. S., Aronin, N., Xu, Z., & Zamore, P. D. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020140 · Cited by 271
Polymeric nanoparticles for siRNA delivery and gene silencing
Patil, Y., & Panyam, J. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.09.039 · Cited by 270
Roles of lipid polymorphism in intracellular delivery
Hafez, I. M., & Cullis, P. R. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00103-x · Cited by 266
Merritt, W. M., Lin, Y. G., Spannuth, W. A., Fletcher, M. S., Kamat, A. A., Han, L. Y., Landen, C. N., Jennings, N., De Geest, K., Langley, R. R., et al. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn024 · Cited by 257
Scheule, R. K., George, J. A. S., Bagley, R. G., Marshall, J., Kaplan, J. M., Akita, G. Y., Wang, K. X., Lee, E. R., Harris, D. J., Jiang, C., et al. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.6-689 · Cited by 251
Martínez, M. A., Gutiérrez, A., Armand-Ugón, M., Blanco, J., Parera, M., Gómez, J., Clotet, B., & Esté, J. A. (2002) · AIDS · doi:10.1097/00002030-200212060-00002 · Cited by 239
Chono, S., Li, S.-D., Conwell, C. C., & Huang, L. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.07.006 · Cited by 238
Self-citationAustin, C. D., Wen, X., Gazzard, L., Nelson, C., Scheller, R. H., & Scales, S. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509035102 · Cited by 237
Therapeutic potential of RNA interference against cancer
Takeshita, F., & Ochiya, T. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00234.x · Cited by 236
Thomas, M., Ge, Q., Lu, J. J., Chen, J., & Klibanov, A. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-1874-y · Cited by 235
Eugen-Olsen, J., Iversen, A. K. N., Garred, P., Koppelhus, U., Pedersen, C., Benfield, T. L., Sorensen, A. M., Katzenstein, T., Dickmeiss, E., Gerstoft, J., et al. (1997) · AIDS · doi:10.1097/00002030-199703110-00007 · Cited by 234
Konno, T., Maeda, H., Iwai, K., Maki, S., Tashiro, S., Uchida, M., & Miyauchi, Y. (1984) · Cancer · doi:10.1002/1097-0142(19841201)54:11<2367::aid-cncr2820541111>3.0.co;2-f · Cited by 233
Cationic lipids enhance siRNA-mediated interferon response in mice
Ma, Z., Li, J., He, F., Wilson, A., Pitt, B., & Li, S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.041 · Cited by 225
Li, S., Wu, S.-P., Whitmore, M., Loeffert, E. J., Wang, L., Watkins, S. C., Pitt, B. R., & Huang, L. (1999) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1999.276.5.l796 · Cited by 225
Self-citationYew, N. S., Zhao, H., Wu, I.-H., Song, A., Tousignant, J. D., Przybylska, M., & Cheng, S. H. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0036 · Cited by 221
Hama, S., Akita, H., Ito, R., Mizuguchi, H., Hayakawa, T., & Harashima, H. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.10.007 · Cited by 211
Martinez, L. A., Naguibneva, I., Lehrmann, H., Vervisch, A., Tchénio, T., Lozano, G., & Harel-Bellan, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222406899 · Cited by 210
Surabhi, R. M., & Gaynor, R. B. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.12963-12973.2002 · Cited by 203
Octaarginine-modified multifunctional envelope-type nano device for siRNA
Nakamura, Y., Kogure, K., Futaki, S., & Harashima, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.03.010 · Cited by 201
LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth
Whitmore, M., Li, S., & Huang, L. (1999) · Gene Therapy · doi:10.1038/sj.gt.3301026 · Cited by 199
Self-citationEfficient Oncogene Silencing and Metastasis Inhibition via Systemic Delivery of siRNA
Li, S.-D., Chono, S., & Huang, L. (2008) · Molecular Therapy · doi:10.1038/mt.2008.51 · Cited by 198
Self-citationKhoury, M., Louis‐Plence, P., Escriou, V., Noel, D., Largeau, C., Cantos, C., Scherman, D., Jorgensen, C., & Apparailly, F. (2006) · Arthritis & Rheumatism · doi:10.1002/art.21876 · Cited by 183
Yan, W., Chen, W., & Huang, L. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.04.009 · Cited by 177
Self-citationLipid composition is important for highly efficient target binding and retention of immunoliposomes.
Maruyama, K., Kennel, S. J., & Huang, L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.15.5744 · Cited by 175
Self-citationHarnessing in vivo siRNA delivery for drug discovery and therapeutic development
Xie, F. Y., Woodle, M. C., & Lu, P. Y. (2006) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03668-8 · Cited by 174
Miller, V. M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh208 · Cited by 172
Webb, M. S., Saxon, D., Wong, F. M. P., Lim, H. J., Wang, Z., Bally, M. B., Choi, L. S. L., Cullis, P. R., & Mayer, L. D. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00077-7 · Cited by 171
Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis
Ding, H., Schwarz, D. S., Keene, A., Affar, E. B., Fenton, L., Xia, X., Shi, Y., Zamore, P. D., & Xu, Z. (2003) · Aging Cell · doi:10.1046/j.1474-9728.2003.00054.x · Cited by 170
Banerjea, A., Li, M.-J., Bauer, G., Remling, L., Lee, N.-S., Rossi, J., & Akkina, R. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00140-0 · Cited by 166
Inhibition of HIV-1 infection by lentiviral vectors expressing pol III-promoted anti-HIV RNAs
Li, M.-J., Bauer, G., Michienzi, A., Yee, J., Lee, N.-S., Kim, J., Li, S. X., Castanotto, D., ZAIA, J. A., & Rossi, J. J. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00165-5 · Cited by 155
Exploitation of Intracellular pH Gradients in the Cellular Delivery of Macromolecules
Asokan, A., & Cho, M. J. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10095 · Cited by 154
Chien, P.-Y., Wang, J., Carbonaro, D., Lei, S., Miller, B., Sheikh, S., Ali, S. M., Ahmad, M. U., & Ahmad, I. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700793 · Cited by 152
Efficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles
Li, S., Chono, S., & Huang, L. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.11.002 · Cited by 151
Self-citationVerbaan, F. J., Oussoren, C., Snel, C. J., Crommelin, D. J. A., Hennink, W. E., & Storm, G. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.475 · Cited by 150
Innate immune response induced by gene delivery vectors
Sakurai, H., Kawabata, K., Sakurai, F., Nakagawa, S., & Mizuguchi, H. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.06.012 · Cited by 144
Woodle, M. C. (1993) · Chemistry and Physics of Lipids · doi:10.1016/0009-3084(93)90069-f · Cited by 142
Maki, S., Konno, T., & Maeda, H. (1985) · Cancer · doi:10.1002/1097-0142(19850815)56:4<751::aid-cncr2820560409>3.0.co;2-y · Cited by 142
Taking polycation gene delivery systems from in vitro to in vivo
Kabanov, A. V. (1999) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(99)00186-8 · Cited by 140
Ewert, K., Ahmad, A., Evans, H. M., & Safinya, C. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.1.33 · Cited by 140
Das, B., Yeger, H., Tsuchida, R., Torkin, R., Gee, M. F. W., Thorner, P. S., Shibuya, M., Malkin, D. M., & Baruchel, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4575 · Cited by 134
Inhibition of Liposome-Induced Complement Activation by Incorporated Poly(Ethylene Glycol)-Lipids
Bradley, A. J., Devine, D. V., Ansell, S. M., Janzen, J., & Brooks, D. E. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0798 · Cited by 132
Small interfering RNA therapy in cancer: mechanism, potential targets, and clinical applications
Huang, C., Li, M., Chen, C., & Yao, Q. C. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.5.637 · Cited by 130
A simple but effective cancer vaccine consisting of an antigen and a cationic lipid
Chen, W., Yan, W., & Huang, L. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0390-4 · Cited by 127
Self-citationPark, W.-S., Miyano-Kurosaki, N., Hayafune, M., Nakajima, E., Matsuzaki, T., Shimada, F., & Takaku, H. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf627 · Cited by 126
Molecular medicine for the brain: silencing of disease genes with RNA interference
Davidson, B. L., & Paulson, H. L. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00678-7 · Cited by 125
Wang, H., Nan, L., Yu, D. S., Agrawal, S., & Zhang, R. (2001) · PubMed · Cited by 123
Hama, S., Akita, H., Iida, S., Mizuguchi, H., & Harashima, H. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl1165 · Cited by 111
Computer-assisted Hydrodynamic Gene Delivery
Suda, T., Suda, K., & Liu, D. (2008) · Molecular Therapy · doi:10.1038/mt.2008.66 · Cited by 107
Simultaneous inhibition of GSK3α and GSK3β using hairpin siRNA expression vectors
Yu, J., Taylor, J., DeRuiter, S. L., Vojtek, A. B., & Turner, D. L. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(02)00037-0 · Cited by 105
Pal, A., Ahmad, A., Khan, S., Sakabe, I., Zhang, C., Kasid, U. N., & Ahmad, I. (2005) · International Journal of Oncology · doi:10.3892/ijo.26.4.1087 · Cited by 104
MicroRNA therapeutics: a new niche for antisense nucleic acids
Hammond, S. M. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.01.004 · Cited by 101
Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts
Yoshizawa, T., Hattori, Y., Hakoshima, M., Koga, K., & Maitani, Y. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.06.026 · Cited by 99
Contribution of Plasmid DNA to Hepatotoxicity after Systemic Administration of Lipoplexes
Loisel, S., Gall, C., Doucet, L., Férec, C., & Floch, V. (2001) · Human Gene Therapy · doi:10.1089/104303401300057405 · Cited by 98
Epstein–Barr Virus/Human Vector Provides High-Level, Long-Term Expression of α1-Antitrypsin in Mice
Stoll, S. M., Sclimenti, C. R., Baba, E. J., Meuse, L., Kay, M. A., & Calos, M. P. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0429 · Cited by 95
Guo, J., Verma, U. N., Gaynor, R. B., Frenkel, E. P., & Becerra, C. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0366 · Cited by 93
Zhao, H., Hemmi, H., Akira, S., Cheng, S. H., Scheule, R. K., & Yew, N. S. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2003.11.012 · Cited by 85
Popielarski, S. R., Hu‐Lieskovan, S., French, S. W., Triche, T. J., & Davis, M. E. (2005) · Bioconjugate Chemistry · doi:10.1021/bc0501146 · Cited by 84
Kumar, L. D., & Clarke, A. R. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.009 · Cited by 84
Lievens, J., Snoeys, J., Vekemans, K., Linthout, S. V., Zanger, R. D., Collen, D., Wisse, E., & Geest, B. D. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302326 · Cited by 80
Non‐immunostimulatory nonviral vectors
Liu, F., Shollenberger, L. M., & Huang, L. (2004) · The FASEB Journal · doi:10.1096/fj.04-2187fje · Cited by 70
Self-citationExploiting EPR in Polymer Drug Conjugate Delivery for Tumor Targeting
Modi, S., Jain, J. P., Domb, A. J., & Kumar, N. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206779026272 · Cited by 69
RNA interference against Hec1 inhibits tumor growth in vivo
Gurzov, E. N., & Izquierdo, M. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302595 · Cited by 66
Uta Griesenbach, D., Kitson, C., Garcia, E. S., Farley, R., Singh, C., Somerton, L., Painter, H. A., Smith, R. L., Gill, D. R., Hyde, S. C., et al. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-26 · Cited by 65
Efficient in vivo gene transfer by PCR amplified fragment with reduced inflammatory activity
Hofman, C., Dileo, J., Li, Z., Li, S., & Huang, L. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301373 · Cited by 65
Self-citationList, A. F., Glinsmann‐Gibson, B., Stadheim, C., Meuillet, E. J., Bellamy, W. T., & Powis, G. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.03.005 · Cited by 61
Fahrmeir, J., Günther, M., Tietze, N., Wagner, E., & Ogris, M. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.013 · Cited by 58
Control of siRNA expression using the Cre-loxP recombination system
Kasim, V. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh061 · Cited by 57
Sakurai, F., Terada, T., Maruyama, M., et al. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700617 · Cited by 47
Short interfering RNA (siRNA), a novel therapeutic tool acting on angiogenesis
Hadj-Slimane, R., Lepelletier, Y., LOPEZ, N., Garbay, C., & Raynaud, F. (2007) · Biochimie · doi:10.1016/j.biochi.2007.06.012 · Cited by 43
Sakurai, H., Sakurai, F., Kawabata, K., Sasaki, T., Koizumi, N., Huang, H., Tashiro, K., Kurachi, S., Nakagawa, S., & Mizuguchi, H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.11.030 · Cited by 40
Silencing of Wnt-1 by siRNA induces apoptosis of MCF-7 human breast cancer cells
Wieczorek, M., Paczkowska, A., Guzenda, P., Majorek, M., Bednarek, A. K., & Lamparska‐Przybysz, M. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.2.5300 · Cited by 38
Kuramoto, T., Nishikawa, M., Thanaketpaisarn, O., et al. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.812 · Cited by 37
Assembly of nucleic acid-lipid nanoparticles from aqueous-organic monophases
Hayes, M. E., Drummond, D. C., Hong, K., et al. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.03.020 · Cited by 35
Kou, R., SenBanerjee, S., Jain, M. K., et al. (2005) · Biochemistry · doi:10.1021/bi0509898 · Cited by 32
hTERT-targeted RNA interference inhibits tumorigenicity and motility of HCT116 cells
Shen, Y., Zhang, Y., Zhang, Z.-X., et al. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.2.5259 · Cited by 30
Seymour, L. W., Olliff, S. P., Poole, C. J., de Takats, P. G., Orme, R., Ferry, D., Maeda, H., Konno, T., & Kerr, D. J. (1998) · International Journal of Oncology · doi:10.3892/ijo.12.6.1217 · Cited by 28
Codelivery of NF-κB Decoy-Related Oligodeoxynucleotide Improves LPD-Mediated Systemic Gene Transfer
Tan, Y., Zhang, J.-S., & Huang, L. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0811 · Cited by 26
Self-citationChan, R. (2006) · Nucleic Acids Research · doi:10.1093/nar/gnj028 · Cited by 19
Liu, F., Conwell, C. C., Xing, Y., Shollenberger, L. M., & Huang, L. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.118117 · Cited by 18
Self-citationEffect of vector-expressed shRNAs on hTERT expression
Guo, Y. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i19.2912 · Cited by 13
Future Directions in the Second-Line Treatment of Non–Small Cell Lung Cancer
Rosell, R., Cecere, F. L., Cognetti, F., Cuello, M. A., Sánchez, J. M., Tarón, M., Reguart, N., & Jablons, D. M. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.12.002 · Cited by 13
Cited by
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Sun, T., Zhang, Y. S., Pang, B., Hyun, D. C., Yang, M., & Xia, Y. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201403036 · Cited by 2,164
The delivery of therapeutic oligonucleotides
Juliano, R. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw236 · Cited by 854
Delivery of siRNA Therapeutics: Barriers and Carriers
Wang, J., Lu, Z., Wientjes, M. G., & Au, J. L.-S. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9210-4 · Cited by 798
The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery
Cheng, X., & Lee, R. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.01.022 · Cited by 703
Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery
Ge, X., Wei, M., He, S., & Yuan, W.-E. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020055 · Cited by 578
Metadata
- Authors
- Tseng, Y.-C., Mozumdar, S., & Huang, L.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2009-07
- Volume
- 61
- Issue
- 9
- Pages
- 721-731
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W1979993551
- Cited by
- 463
- References
- 183
- FWCI
- 1.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.